Glaivy Batsuli

417 total citations
23 papers, 260 citations indexed

About

Glaivy Batsuli is a scholar working on Hematology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Glaivy Batsuli has authored 23 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 7 papers in Genetics and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Glaivy Batsuli's work include Hemophilia Treatment and Research (19 papers), Platelet Disorders and Treatments (15 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Glaivy Batsuli is often cited by papers focused on Hemophilia Treatment and Research (19 papers), Platelet Disorders and Treatments (15 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Glaivy Batsuli collaborates with scholars based in United States, France and Germany. Glaivy Batsuli's co-authors include Shannon L. Meeks, Robert F. Sidonio, Peter A. Kouides, Ernest T. Parker, W. Hunter Baldwin, John F. Healey, Courtney Cox, Pete Lollar, Amanda E. Greene and Brenda Nguyen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PEDIATRICS.

In The Last Decade

Glaivy Batsuli

20 papers receiving 256 citations

Peers

Glaivy Batsuli
Scharrer Germany
Brigitt E. Abbuehl United States
G. Auerswald Germany
L. Rusen United States
Haley Huston United States
Scharrer Germany
Glaivy Batsuli
Citations per year, relative to Glaivy Batsuli Glaivy Batsuli (= 1×) peers Scharrer

Countries citing papers authored by Glaivy Batsuli

Since Specialization
Citations

This map shows the geographic impact of Glaivy Batsuli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glaivy Batsuli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glaivy Batsuli more than expected).

Fields of papers citing papers by Glaivy Batsuli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glaivy Batsuli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glaivy Batsuli. The network helps show where Glaivy Batsuli may publish in the future.

Co-authorship network of co-authors of Glaivy Batsuli

This figure shows the co-authorship network connecting the top 25 collaborators of Glaivy Batsuli. A scholar is included among the top collaborators of Glaivy Batsuli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glaivy Batsuli. Glaivy Batsuli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Batsuli, Glaivy, Suchitra Acharya, Osman Khan, et al.. (2024). Real‐world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi‐institutional case series. Haemophilia. 30(6). 1321–1331. 1 indexed citations
3.
Batsuli, Glaivy, et al.. (2023). Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner. Frontiers in Immunology. 14. 1233356–1233356.
4.
Gee, Beatrice E., et al.. (2023). Assessment of menstrual health in adolescent and young adults with sickle cell disease. Pediatric Blood & Cancer. 71(1). e30727–e30727. 2 indexed citations
5.
Payne, Jeanette, Glaivy Batsuli, Andrew D. Leavitt, Mary Mathias, & Catherine McGuinn. (2022). A review of the pharmacokinetics, efficacy and safety of high‐purity factor X for the prophylactic treatment of hereditary factor X deficiency. Haemophilia. 28(4). 523–531. 6 indexed citations
7.
Batsuli, Glaivy, Amanda E. Greene, Shannon L. Meeks, & Robert F. Sidonio. (2021). Emicizumab in tolerized patients with hemophilia A with inhibitors: A single‐institution pediatric cohort assessing inhibitor status. Research and Practice in Thrombosis and Haemostasis. 5(2). 342–348. 11 indexed citations
8.
Batsuli, Glaivy & Peter A. Kouides. (2021). Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II). Hematology/Oncology Clinics of North America. 35(6). 1181–1196. 16 indexed citations
10.
Baldwin, W. Hunter, Courtney Cox, John F. Healey, et al.. (2021). Removal of single‐site N‐linked glycans on factor VIII alters binding of domain‐specific monoclonal antibodies. Journal of Thrombosis and Haemostasis. 20(3). 574–588. 4 indexed citations
11.
Sidonio, Robert F. & Glaivy Batsuli. (2021). Plasma factor IX: The tip of the iceberg?. Haemophilia. 27(3). 329–331. 2 indexed citations
13.
McGuinn, Catherine, et al.. (2020). Use of plasma‐derived factor X concentrate in neonates and infants with congenital factor X deficiency. Journal of Thrombosis and Haemostasis. 18(10). 2551–2556. 6 indexed citations
14.
Yee, Marianne E., et al.. (2020). Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease. SHILAP Revista de lepidopterología. 9(1). 457–460. 1 indexed citations
15.
Batsuli, Glaivy, et al.. (2019). Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis. Blood. 134(Supplement_1). 1126–1126. 4 indexed citations
16.
Batsuli, Glaivy, et al.. (2019). Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis. Haemophilia. 25(5). 789–796. 58 indexed citations
17.
Batsuli, Glaivy, et al.. (2019). Epitope Dependent Augmentation of the Immune Response in Hemophilia Α Mice Immunized with Factor VIII/Antibody Immune Complexes. Blood. 134(Supplement_1). 2387–2387. 1 indexed citations
18.
Batsuli, Glaivy, W. Hunter Baldwin, Courtney Cox, et al.. (2018). Anti‐C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model. Journal of Thrombosis and Haemostasis. 16(9). 1779–1788. 10 indexed citations
19.
Batsuli, Glaivy, Wei Deng, John F. Healey, et al.. (2016). High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors. Blood. 128(16). 2055–2067. 31 indexed citations
20.
Batsuli, Glaivy, et al.. (2016). Innovating immune tolerance induction for haemophilia. Haemophilia. 22(S5). 31–35. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026